Virovek announces the appointment of Peter L. Hoang as CEO

HOUSTON, TX, October 2, 2023 – Virovek, a commercial-stage biotechnology company specializing in the development, manufacturing and sale of custom-made AAV- and lentivirus-based vectors for therapeutic development, today announced that the Company has appointed Peter...

Virovek Online Store Beta Release

September 13, 2023. Virovek is launching an online storefront for premade product sales. Customers will now be able to add premade AAV to their carts with the click of a button, place their orders entirely online, and have their orders shipped to them anywhere in the...

Virovek is hiring.

Job Title: Jr. Research Associate Job ID#: JRA0608 Employer: Virovek, Inc. Worksite: 8300 Cypress Creek Pkwy., Suite 100, Houston, TX 77070 Responsibilities:  Perform Gene Cloning, Recombinant Baculovirus Generation, and AAV Vector Production;  Experience...

Virovek Now Delivers AAVs in HEK293 Cells

Hayward, California – March 10, 2021 Virovek is pleased to launch a new service line, producing adeno-associated virus (AAV) vector in human embryonic kidney HEK293 cells through three plasmid transfection method. See our HEK293 page for more details and...

Bio-manufacturing and processing summit (ManuBio USA 2013)

Boston, Massachusetts, June 10-11, 2013 — Virovek was invited to present and showcase its large-scale AAV vector manufacturing process at this inaugural bio-manufacturing and processing summit (ManuBio USA 2013) to an audience composed of senior level delegates...